1. Home
  2. RGNX vs CSV Comparison

RGNX vs CSV Comparison

Compare RGNX & CSV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • CSV
  • Stock Information
  • Founded
  • RGNX 2008
  • CSV 1991
  • Country
  • RGNX United States
  • CSV United States
  • Employees
  • RGNX N/A
  • CSV N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • CSV Other Consumer Services
  • Sector
  • RGNX Health Care
  • CSV Consumer Discretionary
  • Exchange
  • RGNX Nasdaq
  • CSV Nasdaq
  • Market Cap
  • RGNX 661.2M
  • CSV 670.2M
  • IPO Year
  • RGNX 2015
  • CSV 1996
  • Fundamental
  • Price
  • RGNX $13.08
  • CSV $44.93
  • Analyst Decision
  • RGNX Strong Buy
  • CSV Strong Buy
  • Analyst Count
  • RGNX 7
  • CSV 4
  • Target Price
  • RGNX $30.00
  • CSV $59.00
  • AVG Volume (30 Days)
  • RGNX 602.9K
  • CSV 69.5K
  • Earning Date
  • RGNX 11-06-2025
  • CSV 11-05-2025
  • Dividend Yield
  • RGNX N/A
  • CSV 1.02%
  • EPS Growth
  • RGNX N/A
  • CSV 75.49
  • EPS
  • RGNX N/A
  • CSV 3.32
  • Revenue
  • RGNX $155,782,000.00
  • CSV $407,603,000.00
  • Revenue This Year
  • RGNX $198.02
  • CSV $3.97
  • Revenue Next Year
  • RGNX $2.67
  • CSV $3.40
  • P/E Ratio
  • RGNX N/A
  • CSV $13.58
  • Revenue Growth
  • RGNX 74.95
  • CSV 3.15
  • 52 Week Low
  • RGNX $5.04
  • CSV $32.31
  • 52 Week High
  • RGNX $13.93
  • CSV $49.41
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 57.58
  • CSV 48.80
  • Support Level
  • RGNX $12.66
  • CSV $44.76
  • Resistance Level
  • RGNX $13.93
  • CSV $45.49
  • Average True Range (ATR)
  • RGNX 0.69
  • CSV 0.88
  • MACD
  • RGNX -0.05
  • CSV -0.07
  • Stochastic Oscillator
  • RGNX 57.85
  • CSV 45.10

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About CSV Carriage Services Inc.

Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.

Share on Social Networks: